Rhodococcus ruber Cell Wall Components for Oral Lichen Planus
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for oral lichen planus are plagued by side effects such as mucosal atrophy, infections, and systemic adverse reactions, particularly with long-term use of glucocorticoids, necessitating the development of a safe and effective medicament without significant side effects.
Innovation Solution
The use of isolated Rhodococcus ruber cell wall components, including proteins, nucleic acids, lipids, and carbohydrates, derived from Rhodococcus ruber, are formulated into pharmaceutical compositions for topical or systemic administration to treat oral lichen planus, with the cell wall skeleton being a key component.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If glucocorticoids are used to treat oral lichen planus, then therapeutic efficacy is improved, but side effects such as mucosal atrophy, infections, and systemic adverse reactions increase
Solution Approach 1:
The patent extracts and utilizes specific cell wall components (peptidoglycan, teichoic acid, lipoteichoic acid) from Rhodococcus ruber bacteria as the active therapeutic agents. This extraction principle allows obtaining the beneficial immunomodulatory effects while eliminating the harmful side effects associated with glucocorticoid use, thereby resolving the contradiction between efficacy and safety
Solution Approach 2:
The Rhodococcus ruber cell wall components act as an intermediary substance that modulates the immune system to treat oral lichen planus. Unlike glucocorticoids that directly suppress immunity causing side effects, these bacterial cell wall components serve as a natural immunomodulator that achieves therapeutic effects through intermediate immune regulation mechanisms, reducing harmful effects while maintaining efficacy
2Duration of action of stationary object
If long-term glucocorticoid treatment is administered, then therapeutic effect is maintained, but cumulative side effects and systemic adverse reactions worsen
Solution Approach 1:
The patent employs biodegradable cell wall components from Rhodococcus ruber that can be administered repeatedly over time without accumulating harmful effects. These natural components are metabolized and eliminated by the body, allowing for long-term treatment protocols similar to glucocorticoids but without the cumulative toxicity and systemic adverse reactions that limit long-term glucocorticoid use
Data Source
AI summary
Isolated Rhodococcus ruber, a product derived from the Rhodococcus ruber (in particular, a product derived from the Rhodococcus ruber cell wall), a method for preparing the product derived from the Rhodococcus ruber, and use of the product derived from the Rhodococcus ruber in prevention and/or treatment of lichen planus. The product derived from the Rhodococcus ruber effectively reduce the erosion area of lichen planus and relieve pain.